IBT
VSTM icon

International Biotechnology Trust’s Verastem VSTM Stock Holding History

International Biotechnology Trust’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-41,667
Closed -$3.44M – 55
2018
Q2 		$3.44M Buy
41,667
+8,334
+25% +$510K 1.32% 26
2018
Q1 		$1.19M Buy
+33,333
New +$1.29M 0.47% 47

Other funds holding VSTM

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

International Biotechnology Trust's VSTM Position: Q3 2018 in Review

International Biotechnology Trust sold out of Verastem (VSTM) in Q3 2018, closing a stake of 41,667 shares — an estimated $3.44M sold.

International Biotechnology Trust first reported a position in VSTM in Q1 2018 and held it in 2 quarters. The position peaked at $3.44M in Q2 2018. 112 funds tracked by Wall St. Rank hold VSTM as of Q3 2018.

  • International Biotechnology Trust reported no remaining Verastem position as of Q3 2018 after selling out during the quarter.
  • International Biotechnology Trust sold 41,667 Verastem shares in Q3 2018, an estimated $3.44M.
  • International Biotechnology Trust first reported a position in Verastem in Q1 2018 and held it in 2 quarters.
  • International Biotechnology Trust's Verastem position peaked at $3.44M in Q2 2018.
  • 112 funds tracked by Wall St. Rank held Verastem as of Q3 2018.

Based on International Biotechnology Trust's 13F filing for Q3 2018, filed 13 Nov 2018.